Ascentage Pharma Group International (AAPG) Q1 2026 Earnings

24MarConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.24
-0.14
-0.03
0.08

Details

Expected EPS
-0.20929286816
Actual EPS
-0.16034779592
Surprise EPS
0.05
Surprise Percent
+23.39%

Description

Ascentage Pharma Group International (AAPG) has reported earnings of -0.16034779592 per share for Q1 2026.

0 Comments

Share your thoughts